Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NVDA
9. FDXF
10. RKLB

Go back to Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program
(NASDAQ: VALN) Delayed: 5.19 -0.02 (0.38%)
Previous Close $5.21    52 Week High $ 
Open $5.05    52 Week Low $ 
Day High $5.22    P/E N/A 
Day Low $5.04    EPS $ 
Volume 27,494